Skip to content

CYCLO THERAPEUTICS, INC.: 10-Q filed 2019-08-13

What CYCLO THERAPEUTICS, INC. reported in its quarterly report filed 2019-08-13 (fiscal Q2 2019): 24 published measures, 62 facts as tagged in accession 0001437749-19-016546.

This filing

Form
10-Q (quarterly report)
Filed
2019-08-13
Fiscal period
fiscal Q2 2019
Accession
0001437749-19-016546 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYCLO THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-06-307,591,024USD
At 2018-12-312,917,856USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-304,840,009USD
At 2019-03-31-781,580USD
At 2018-12-31992,524USD
At 2018-06-301,003,445USD
At 2018-03-31332,674USD
At 2017-12-311,145,618USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-06-306,607,613USD
At 2018-12-312,217,412USD
At 2018-06-301,541,030USD
At 2017-12-311,270,973USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-1,368,011USD91
2019-01-01 to 2019-06-30-3,272,177USD181
2019-01-01 to 2019-03-31-1,904,166USD90
2018-04-01 to 2018-06-30-1,289,229USD91
2018-01-01 to 2018-06-30-2,102,173USD181
2018-01-01 to 2018-03-31-812,944USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-2,746,667USD181
2018-01-01 to 2018-06-30-1,706,068USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-06-301,324USD181
2018-01-01 to 2018-06-301,634USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-06-307,119,662USD181
2018-01-01 to 2018-06-301,960,000USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-06-3017,206USD181
2018-01-01 to 2018-06-3016,125USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-20,859,877USD
At 2018-12-31-17,587,700USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-06-3016,926USD
At 2018-12-3118,571USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-1,370,284USD91
2019-01-01 to 2019-06-30-3,278,074USD181
2018-04-01 to 2018-06-30-1,294,740USD91
2018-01-01 to 2018-06-30-2,109,116USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-06-307,403,435USD
At 2018-12-312,769,611USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-302,704,814USD
At 2018-12-311,925,332USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-06-30154,110USD
At 2018-12-3180,044USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-06-30397,584USD
At 2018-12-31416,531USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-04-01 to 2019-06-30786,811USD91
2019-01-01 to 2019-06-302,129,574USD181
2018-04-01 to 2018-06-30844,376USD91
2018-01-01 to 2018-06-301,253,574USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-30120,529,324shares
At 2018-12-3190,759,324shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-06-3025,687,834USD
At 2018-12-3118,701,211USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-06-3059,519USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-06-30178,200USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-1,368,011USD91
2019-01-01 to 2019-06-30-3,272,177USD181
2018-04-01 to 2018-06-30-1,289,229USD91
2018-01-01 to 2018-06-30-2,102,173USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-06-302,969USD181
2018-01-01 to 2018-06-305,026USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-3074,066USD181
2018-01-01 to 2018-06-3034,567USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-18,947USD181
2018-01-01 to 2018-06-30-63,635USD181

Inspect the source

Entity
CYCLO THERAPEUTICS, INC. / CIK 0000922247
Captured
2026-09-21T17:17:43.874Z
SEC response SHA-256
00eb7fd40e8240f18174ace9c17e250765347f97ee2730b0222250298ac67de3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000922247.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))